Marker Therapeutics, Inc. (MRKR)
1.50
+0.11
(+7.91%)
USD |
NASDAQ |
Aug 24, 16:00
1.50
0.00 (0.00%)
After-Hours: 19:59
Marker Therapeutics Price to Book Value : 2.056 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.905 |
| August 20, 2026 | 1.672 |
| August 19, 2026 | 1.768 |
| August 18, 2026 | 1.576 |
| August 17, 2026 | 1.590 |
| August 14, 2026 | 1.562 |
| August 13, 2026 | 1.521 |
| August 12, 2026 | 1.590 |
| August 11, 2026 | 1.535 |
| August 10, 2026 | 1.576 |
| August 07, 2026 | 1.535 |
| August 06, 2026 | 1.535 |
| August 05, 2026 | 1.562 |
| August 04, 2026 | 1.686 |
| August 03, 2026 | 1.672 |
| July 31, 2026 | 1.549 |
| July 30, 2026 | 1.535 |
| July 29, 2026 | 1.521 |
| July 28, 2026 | 1.617 |
| July 27, 2026 | 1.672 |
| July 24, 2026 | 1.672 |
| July 23, 2026 | 1.741 |
| July 22, 2026 | 1.699 |
| July 21, 2026 | 1.741 |
| July 20, 2026 | 1.754 |
| Date | Value |
|---|---|
| July 17, 2026 | 1.795 |
| July 16, 2026 | 1.836 |
| July 15, 2026 | 1.932 |
| July 14, 2026 | 1.974 |
| July 13, 2026 | 2.001 |
| July 10, 2026 | 2.070 |
| July 09, 2026 | 2.165 |
| July 08, 2026 | 2.206 |
| July 07, 2026 | 2.302 |
| July 06, 2026 | 2.028 |
| July 02, 2026 | 2.015 |
| July 01, 2026 | 1.987 |
| June 30, 2026 | 2.015 |
| June 29, 2026 | 1.764 |
| June 26, 2026 | 1.589 |
| June 25, 2026 | 1.583 |
| June 24, 2026 | 1.583 |
| June 23, 2026 | 1.656 |
| June 22, 2026 | 1.656 |
| June 18, 2026 | 1.607 |
| June 17, 2026 | 1.632 |
| June 16, 2026 | 1.632 |
| June 15, 2026 | 1.632 |
| June 12, 2026 | 1.668 |
| June 11, 2026 | 1.656 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Krystal Biotech, Inc. | 7.442 |
| Tenaya Therapeutics, Inc. | 2.160 |
| Ironwood Pharmaceuticals, Inc. | -- |
| Vericel Corp. | 5.857 |
| SELLAS Life Sciences Group, Inc. | 21.01 |
Price to Book Value Related Metrics
| PS Ratio | 11.57 |
| Price | 1.50 |
| Earnings Yield | -32.05% |
| Market Cap | 25.01M |